IGF-1 signaling plays multiple roles in the CNS, and its potential beneficial role in AD and other dementias helps make the case for the IGF system as a therapeutic target in neurodegenerative diseases, including AD16. This evidence concerns the gene IGF1 and Alzheimer disease.